Aug. 5 at 11:56 AM
$SHPH Pursuant to this prospectus, the selling stockholder identified herein is offering on a resale basis 1,180,877 shares of common stock of Shuttle Pharmaceuticals Holdings, Inc., consisting of (i) 21,924 outstanding shares and (ii) 1,158,953 shares issuable upon exercise of pre-funded warrants, each exercisable into one share of common stock at a nominal exercise price per share of
$0.001, without expiration. The outstanding shares of common stock and the pre-funded warrants were issued to the selling stockholder in connection with a private placement we completed on June 24, 2025. We will not receive any of the proceeds from the sale by the selling stockholder of the shares.
